Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1998
10/08/1998WO1998020124A3 Diabetes-mediating proteins and therapeutic uses thereof
10/08/1998WO1998018930A3 Streptococcus pneumoniae antigens and vaccines
10/08/1998WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/08/1998WO1998005760A3 Phosphate starvation-inducible proteins
10/08/1998WO1998004692A3 Human neuronatin
10/08/1998DE19815128A1 Transgenic animal model for human cardio-myopathy
10/08/1998DE19722317C1 New human ryanodin receptor type 3 polypeptide
10/08/1998DE19713393A1 Flip-Gen und Flip-Protein Flip gene and flip-protein
10/08/1998CA2286893A1 76 kda, 32 kda, and 50 kda helicobacter polypeptides and corresponding polynucleotide molecules
10/08/1998CA2286306A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998CA2286284A1 Plant pest control
10/08/1998CA2285692A1 Enhancement of immune response using targeting molecules
10/08/1998CA2285669A1 Flip gene and flip protein
10/08/1998CA2285631A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998CA2285625A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
10/08/1998CA2285622A1 Chemokine beta-6
10/08/1998CA2285565A1 Modified adenoviral fiber and target adenoviruses
10/08/1998CA2285452A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
10/08/1998CA2285447A1 Secreted proteins and polynucleotides encoding them
10/08/1998CA2285039A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
10/08/1998CA2285038A1 Treatment for dutch elm disease
10/08/1998CA2284846A1 Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene
10/08/1998CA2284734A1 Novel membrane-secreted protein
10/08/1998CA2284730A1 Methods of modulating p33ing1 mediated apoptosis
10/08/1998CA2284686A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
10/08/1998CA2283934A1 Recombinant protein c and protein s variants
10/08/1998CA2283834A1 Glucagon-like peptide-1 analogs
10/08/1998CA2253929A1 Preventive and/or therapeutic agent for kidney diseases
10/08/1998CA2227932A1 Gene encoding invasion protein of campylobacter jejuni
10/07/1998EP0869187A2 Replication of nucleic acids using single-strand DNA binding proteins
10/07/1998EP0869184A2 Vaccin for immunisation against TBE viral infections and method or its preparation
10/07/1998EP0869181A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
10/07/1998EP0869180A1 A TNF homologue, TL5
10/07/1998EP0869179A1 Tumor necrosis related receptor, TR7
10/07/1998EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998EP0869177A2 Human a- and b- platelet-derived growth factor receptor proteins and uses therefor.
10/07/1998EP0869176A1 Autoantigens
10/07/1998EP0869175A2 Cytochrome C and its gene
10/07/1998EP0869167A2 Reduction of phosphorus containing components in edible oils comprising a high amount of non-hydratable phosphorus by use of a phospholipase, a phospholipase from a filamentous fungus having phospholipase A and/or B activity
10/07/1998EP0869135A1 Glucagon-like peptide-1 analogs
10/07/1998EP0869134A1 Process for recovering growth factors, or a composition containing one or more growth factors, from milk or a milk derivative
10/07/1998EP0869133A1 Production of gonorrheal PIB proteins and vaccines
10/07/1998EP0868920A2 Hybrid protein for treatment of bladder cancer cells
10/07/1998EP0868536A1 Genetic suppressor elements against human immunodeficiency virus
10/07/1998EP0868533A1 The pig myogenin gene and method to identify polymorphisms related to muscle growth
10/07/1998EP0868532A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE
10/07/1998EP0868527A2 Process for the microbial production of amino acids by boosted activity of export carriers
10/07/1998EP0868524A2 Improved barstar gene
10/07/1998EP0868523A1 Vector for expression of n-terminally extended proteins in yeast cell
10/07/1998EP0868522A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/1998EP0868521A2 Globins containing binding domains
10/07/1998EP0868517A1 Component of a staphylococcus signal transduction system
10/07/1998EP0868516A1 Novel tcts response regulator of staphylococcus aureus
10/07/1998EP0868515A1 Component of a staphylococcus signal transduction system
10/07/1998EP0868514A2 Dna encoding phage abortive infection protein from lactococcus lactis, and method of use thereof
10/07/1998EP0868513A1 TGF$g(b) SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO
10/07/1998EP0868512A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
10/07/1998EP0868511A1 Utrophin gene expression
10/07/1998EP0868510A2 P2u2 PURINERGIC RECEPTOR
10/07/1998EP0868433A1 Identification of antigenes from post-infection nematodes for the purpose of developing new anthelmintics and vaccines
10/07/1998EP0868431A1 Protein with plant protecting properties
10/07/1998EP0868430A1 Therapeutic compositions
10/07/1998EP0868429A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/07/1998EP0868427A1 Methods for identifying compounds that bind to a target
10/07/1998EP0868426A1 Chemically-inducible arabidopsis pr-1 promoter
10/07/1998EP0868201A1 Detecting prions in a sample and prion preparation and transgenic animal used for same
10/07/1998EP0868196A1 Synthetic vaccine for protection against human immunodeficiency virus infection
10/07/1998EP0837875A4 Inhibitors of farnesyl-protein transferase
10/07/1998EP0804734A4 Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
10/07/1998EP0765165A4 Constrained peptides
10/07/1998EP0703923B1 Factor vii-derived peptides
10/07/1998EP0654042B1 Amylin muteins
10/07/1998EP0548123B1 Anti-inflammatory factor, method of isolation, and use
10/07/1998CN1195376A Method for expression of foreign genes and vectors therefor
10/07/1998CN1195375A Angiostatin fragments and aggregate angiostatin and methods of use
10/07/1998CN1195374A Cytoplasmic modulators of integrin regulation/signaling
10/07/1998CN1195297A Clostridium difficile toxins as mucosal adjuvants
10/07/1998CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998CN1195294A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligang antibodies, as therapeutic agents for treatment of immunological disease
10/07/1998CN1195293A Method for treating disbetes
10/07/1998CN1195026A Stress resistant plant in which cell death suppressing gene is introduced and method for producing same
10/07/1998CN1194986A Anti-obesity proteins
10/07/1998CN1040126C Process for preparing protein
10/06/1998US5817912 Transgenic mice with disrupted NPY Y1 receptor genes
10/06/1998US5817911 Transgenic mice expressing alveolar MCP-1
10/06/1998US5817811 Amidation of the correspond esterified amine compound with a carboxylated nucleotide base
10/06/1998US5817796 C-myb ribozymes having 2'-5'-linked adenylate residues
10/06/1998US5817792 DNA sequences encoding HIV-1 envelope muteins containing hypervariable domain deletions
10/06/1998US5817789 Bind to cell surface receptors; genetic engineering
10/06/1998US5817787 Probes and methods for detecting melanocortin-5 receptor
10/06/1998US5817785 Methods of producing nucleic acid ligands
10/06/1998US5817784 Polypeptide termined neuritin which is expressed primary in brain tissue
10/06/1998US5817782 Controlling stability and tolerance of stress; longevityassurance gene
10/06/1998US5817773 Stimulation, production, culturing and transplantation of stem cells by fibroblast growth factors
10/06/1998US5817771 Cell-targeted lytic pore-forming agents
10/06/1998US5817769 Antibodies to mammalian adipogenic factors
10/06/1998US5817767 Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
10/06/1998US5817765 Purification of plasma proteins
10/06/1998US5817763 Cytokine
10/06/1998US5817762 Mammalian tub protein
1 ... 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 ... 2916